Proteomics International receives $2.0m in R&D tax incentive

Proteomics International Laboratories Ltd (Proteomics International; the Company; ASX: PIQ), a pioneer in precision diagnostics, is pleased to announce that its cash reserves have been strengthened by the receipt of a $2.0 million research and development (R&D) tax incentive for the 2025-26 financial year.

The Federal R&D tax incentive encourages companies engaging in research beneficial to Australia by providing a cash rebate of 43.5% for eligible expenditure on qualifying activities. In the 2025-26 financial year, Proteomics International Laboratories Ltd and its subsidiaries incurred $4.6 million of eligible R&D expenditure, enabling the Company to receive a $2.0 million rebate.

View ASX Announcement: here